Introduction: Although lipid profiles tend to worsen with age, it is not fully known if such age-related changes are influenced primarily by body composition and lifestyle or by other aspects of aging. Objective: We investigated the extent to which the fat and fat-free components of body mass index (BMI) and lifestyle factors influence patterns of change in lipids independent of age. Design: Serial data were analyzed using sex-specific longitudinal models. These models use serial data from individuals to assume a general pattern of change over time, while allowing baseline age and the rate of change to vary among individuals. Subjects: Serial data were obtained from 940 examinations of 269 healthy white participants (126 men, 143 women), aged 40-60 years, in the Fels Longitudinal Study. Measurements: Measurements included age, the fat (FMI) and fat-free mass (FFMI) components of BMI, high-density lipoprotein (HDL-C), low-density lipoprotein (LDL-C), triglycerides (TG), total cholesterol (TC), fasting glucose and insulin, physical activity, alcohol use and smoking, and women's menopausal status and estrogen use. Results: In both sexes, increased FMI was significantly associated with increased LDL-C, TG and TC, and decreased HDL-C. Increased FFMI was significantly related to decreased HDL-C and increased TG. Independent age effects remained significant only for LDL-C and TC in men and TC in women. Increased insulin was significantly related to increased TG in women. Moderate alcohol consumption was associated with higher HDL-C in men. Physical activity lowered male LDL-C and TC levels, and increased female HDL-C levels. Menopause was associated with increases in LDL-C. Premenopausal women not using estrogen had significantly lower HDL-C, TG, and TC than postmenopausal women taking estrogen. Conclusions: (1) Age is an important independent predictor for LDL-C and TC in men, and TC in women, but it is not as influential as body composition and lifestyle on HDL-C and TG in men and women, and LDL-C in women. (2) Increasing FMI is the major contributor to elevated TC, LDL-C and TG levels, and decreased HDL-C levels in men and women. (3) FFMI significantly influences HDL and TG levels in both sexes. (4) Maintaining a lower BMI via a reduced fat component may be more beneficial in lowering CVD risks than other factors.
Introduction
Adverse lipid and lipoprotein profiles have been established as risk factors for many chronic conditions, including cardiovascular and coronary artery diseases, and metabolic perturbations such as diabetes. Most often, age has been found to be associated with changes in lipid and lipoprotein concentrations. For example, several investigators have described age-related changes in lipid and lipoprotein levels, including increases in low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and total cholesterol (TC), and decreases in high-density lipoprotein cholesterol (HDL-C) up to middle age. [1] [2] [3] [4] [5] [6] [7] Physical activity and moderate alcohol consumption are related to decreases in LDL-C and TC, and increases in HDL-C. [8] [9] [10] In women, the menopausal transition is strongly associated with increases in LDL-C and TC, and in some studies with changes in TG and HDL-C. 2, [11] [12] [13] [14] The majority of these findings, however, are from analyses of cross-sectional data, or from data gathered in studies that had relatively short follow-up periods. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Adiposity is an important influence on adult lipid and lipoprotein profiles. [15] [16] [17] [18] [19] [20] [21] The body mass index (BMI) is often used as a proxy measure of adiposity and in adults BMI is positively related to LDL-C, TG and TC, and negatively related to HDL-C. 22 However, BMI is a composite of adipose and lean tissues, both of which can have distinct effects on lipid and lipoprotein levels. Unfortunately, the relative contributions of fat and lean tissue to variation in lipid and lipoprotein levels are indistinguishable when adjusting only for BMI or percent body fat. For example, two individuals with the same BMI or percent body fat values might have the same fat mass but have different fat-free mass (FFM), the same FFM but with different fat mass, or different fat and fat-free mass. One way to account for both adipose and lean tissues in analyses using BMI is to decompose BMI into separate components of fat-and fat-free mass. These components are called, respectively, the fat mass index (FMI) and fat-free mass index (FFMI). 23 These two indices are computed separately as a ratio of total body fat (TBF) and FFM to height-squared. As such, these indices provide a way to examine relative contributions of TBF and FFM independent of individual stature. In addition, it has been shown that the FMI and the FFMI, as measures of body composition independent of height, are useful assessment indices for nutrition status in adults, 23 and reference values for these indices have been published. 24, 25 In this paper, we extend our earlier work 6 and that of others by using long-term serial data from the Fels Longitudinal Study to examine simultaneous effects of age, the FMI and FFMI, and concurrent measures of lifestyle variables on lipid and lipoprotein levels. These long-term data allowed pertinent covariates to be treated as time-varying in order to better evaluate patterns of change in lipid and lipoprotein values as lifestyle changed, and for women, as transition through menopause occurred. In this manner, we simultaneously examined these effects on lipid and lipoprotein concentrations to determine whether or not the age-related changes in these disease risk factors are influenced more by changes in body composition and lifestyle factors, or more by other aspects of aging as yet unexamined. Specifically, we (1) describe age-related changes in lipid and lipoprotein measures of HDL-C, LDL-C, TG, and TC in middle-aged men and women, (2) determine the extent to which the patterns of change in these measures are influenced by changes in body composition as represented by the FMI and FFMI, and (3) examine the influence of glucose metabolism and important lifestyle and life status variables on changes in HDL-C, LDL-C, TG, and TC.
Subjects and data collection methods Serial data were collected from a subset of healthy white men and women, aged 40-60 years, participating in the Fels Anthropometry and body composition Stature (cm) was measured to 0.1 cm using a Holtain stadiometer (Seritex, Carlstadt, NJ, USA) and weight was measured to 0.1 kg on an examination scale using standard anthropometric techniques. 27 Stature and weight were used to calculate BMI (kg/m 2 ). TBF and FFM were calculated from the body composition model of Siri using hydrodensitometryderived measures of body density and residual volume. 28 Residual volume was measured on a Gould 2100 computerized spirometer (Gould Instrument Systems, Valley View, OH, USA). To determine the relative portions of TBF and FFM represented by BMI, the body composition measures of TBF and FFM were used to partition BMI into the FMI and the FFMI as follows:
The FMI and FFMI used in this paper are similar to those proposed by VanItallie et al., 23 except that the indices in this paper were computed from measures of TBF and FFM derived by hydrodensitometry instead of total body electrical conductivity.
Blood data
Fasting blood samples were collected at each examination. Plasma lipid and lipoprotein measures of HDL-C, LDL-C, TG, and TC, as well as insulin concentrations, were made at the Medical Research Laboratory (Highland Heights, KY, USA), which participates in the NHLBI/CDC Lipid Standardization Program. 29 Fasting glucose was measured at the Lifespan Health Research Center by laboratory staff using a Vitros DT6011 blood chemistry system (Ortho-Clinical Diagnostics, Raritan, NJ, USA).
Time-varying covariates
Self-reported questionnaire data were used to characterize alcohol use, smoking behavior, and physical activity level at each examination. For alcohol use, subjects were classified as non-or infrequent drinkers if they either consumed no alcohol or consumed alcohol once a month or less. Subjects were classified as current drinkers if they consumed alcohol Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age CM Schubert et al more than once a month. For smoking, subjects were classified as either current smokers or nonsmokers. Physical activity was assessed at each examination using the Baecke Questionnaire for Habitual Physical Activity. 30 This questionnaire scores individuals on their overall physical activity by a summation of subscores for work, leisure time, and sport activities. Specifics of this questionnaire and its reliability are reported elsewhere. [30] [31] [32] [33] Menopausal status in women at each examination was determined from interview-administered questionnaires regarding menstrual and reproductive history. A woman was classified as postmenopausal if she had reported either missing 12 or more menstrual periods in a row prior to the examination (i.e. one year without menses), or had undergone a hysterectomy with oophorectomy. A woman was classified as perimenopausal if she reported missing between three and 11 menstrual periods, or was still menstruating and reported other significant cycle changes or vasomotor symptoms of menopause (e.g., hot flashes). A woman was classified as premenopausal if she experienced normal menstrual cycles. Estrogen use (hormone replacement therapy or oral contraception containing an estrogen component) was recorded as either 'yes' or 'no' at each examination.
All covariates were treated as time-varying because subjects could change classifications for any of the measures during the collection of these serial data. For example, a man may have been a smoker at his first examination, but he may have quit by his next examination. Thus, his smoking classification would change from 'smoker' to 'nonsmoker.' Likewise, a woman may have been premenopausal with no estrogen use at one examination, but at a subsequent examination, she may report becoming postmenopausal and taking an estrogen replacement. Thus, her classifications would have changed from 'premenopausal' and 'estrogen-no' to 'postmenopausal' and 'estrogen-yes.' Treating these covariates as time-varying allows for better characterization of these factors on observed changes in lipid and lipoprotein measures over time.
Statistical methods
Age-and sex-specific descriptive statistics, including means and standard deviations, were calculated for HDL-C, LDL-C, TG, TC, BMI, FMI, and FFMI. Sex differences at each age were evaluated using t-tests and the Kruskal-Wallis test for nonnormally distributed data. Mean values were plotted by age and overall trends were examined. Age at first and last examination and mean values for length of time between first and last examinations were calculated for all subjects, as were the proportions of men and women smoking, consuming alcohol, and those whose classification changed because they stopped smoking or consumed less alcohol. For women, age at onset of menopause and proportions of those using or not using estrogen were calculated.
Random effects mixed models were used to quantify agerelated changes in HDL-C, LDL-C, TG, and TC. These models assume a general pattern of change over time, while accounting for individual variability. 34, 35 This is achieved by considering the parameter estimates, intercepts, and slopes from these models as either fixed or random. For instance, a model with a random slope implies that the rates of change in the response variable differ from individual to individual. This modeling was conducted in several steps in order to accomplish the objectives of this paper: (1) describe age-related changes in HDL-C, LDL-C, TG and TC, (2) determine the influence of the FMI and FFMI on these agerelated changes, and (3) examine the influence of important lifestyle and life status variables on these changes, in addition to concurrent glucose and insulin levels. First, age-related changes in HDL-C, LDL-C, TG, and TC were examined using only age and age 2 as predictor variables. The FMI and FFMI were then included with age and age 2 as predictor variables to determine if changes in the FMI and FFMI would account for any of the age-related changes in measures of lipid and lipoproteins. Finally, each model was examined for additional effects of glucose and insulin levels and potential covariates including alcohol use, smoking, physical activity, and menopausal status and estrogen use in women. Each random effects model was scaled to begin with measurements starting at 40 years of age. Thus, age was calculated as 'age -40', and the response variables of HDL-C, LDL-C, TG and TC, and the predictor variables of FMI and FFMI were calculated as the individual's status value at each examination minus the sex-specific mean value for the variable at age 40 years. At each stage of modeling, significance of parameter estimates and likelihood ratio tests were used to evaluate the addition of predictor variables. Predictor variables that were not statistically significant were excluded from the final model. In order to quantify the resulting level of differences in HDL-C, LDL-C, TG, and TC between menopausal status and estrogen use in women, least-squared means from the mixed model were computed and significant differences were identified using Tukey's procedure for multiple comparisons. Additional variables were added to each final model for women and the resulting parameter estimates were examined to ensure that there were no significant differences in trends between surgically and naturally postmenopausal women. All modeling analyses were conducted at the a ¼ 0.05 level of significance using PROC MIXED in SAS v8.02. 36 
Results
Summary descriptions of the study subjects are given in Table 1 . The length of serial observations for the subjects ranged from 2 to 20 years and averaged about 9 years for men and women. Approximately 76% of the subjects had serial Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age CM Schubert et al examinations spanning at least 5 years, and about 15% of subjects had examinations spanning 15 years or more. More men than women consumed tobacco and alcohol. Roughly 21% of men and 16% of women smoked and about 77% of men and 74% of women were classified as frequent drinkers throughout the study period. About 9% of men and 10% of women became non-or infrequent drinkers and 6% of men and 10% women stopped smoking during the study period. About 22% of men and women were classified as having elevated glucose levels (fasting glucose 4100) at the time of their last examination. 37 Almost half (47%) of all women transitioned through menopause over the course of their examinations, with an average age at onset of menopause of about 46 years (range: 21-58 years). Over one-third of women had undergone surgical menopause, with an average age of surgical menopause of about 43 years as compared to an average age of onset of 48 years for women reporting natural menopause. Overall, 67 women transitioned to postmenopause, 31 transitioned to perimenopause, 16 remained premenopausal, seven remained peri-menopausal, and 22 remained postmenopausal by their final examination.
Age-and sex-specific means for HDL-C, LDL-C, TG, TC, BMI, FMI, and FFMI are given in Table 2 . In general, men had significantly lower HDL-C than women, and younger men had higher LDL-C, TG, and TC than similarly aged women. Compared to women, men had a significantly higher FFMI at all ages, and a significantly lower FMI at all but one age point (58 years). BMI was slightly higher in men than women, but was not significantly different except at 58 years. Compared to published reference values, mean FFMI in men and women was about average, corresponding to about the 50th percentile for all ages in men and women. 24, 25 The FMI was higher at all ages in both men and women compared to published norms, occurring between the 75th and 90th percentiles in men and the 50th to 75th percentiles in women.
24,25
Age-related changes Sex-specific models describing age-related changes in HDL-C, LDL-C, TG, and TC are presented in Table 3 . Age did not describe any patterns of change in HDL-C for men or women. There were significant, linear age-related increases in TG, and curvilinear effects of age on LDL-C and TC in both sexes. On average, TG increased by about 2 mg/dl in men and 4 mg/dl in women each year. The curvilinear effects of age on LDL-C and TC exhibited average increases up to about 52 years of age in men and 58 years of age in women, Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age CM Schubert et al after which LDL-C and TC either plateaued or began to decrease.
Changes with Age, FMI, and FFMI To determine if FMI and FFMI influence changes in HDL-C, LDL-C, TG, and TC, these components were added to the first set of models. As FMI increased, significant increases in LDL-C, TG, and TC, and decreases in HDL-C were observed for men and women (Table 4) . Increases in FFMI were significantly related to decreases in HDL-C and increases in TG, but not to LDL-C or TC in either men or women. Age remained significantly related to LDL-C and TC in both sexes, and to TG in women, but was no longer a significant predictor of TG in men once FMI and FFMI were included in the models. The final sex-specific, best-fitting model for each response variable is presented in Table 5 . These models build on the ones presented in Table 4 (in which age, FMI, and FFMI were considered as predictor variables) by accounting for the potentially important covariates of concurrent glucose and insulin values, alcohol use, smoking and physical activity, and menopausal status and estrogen use in women.
Men
The final models for men show no significant effects of age on HDL-C or TG, but holding other variables in the model constant, LDL-C and TC both increased with age until about 50 years. With increasing FMI, there were significant increases in LDL-C, TG and TC, and decreases in HDL-C. For example, on average, an increase in FMI of 1 kg/m 2 increased LDL-C by about 3 mg/dl, TG by about 12 mg/dl and TC by about 5 mg/dl, and lowered HDL-C by 1 mg/dl. FFMI was significantly related to HDL-C and TG, but not to LDL-C or TC. On average, an increase in FFMI of 1 kg/m 2 increased Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age CM Schubert et al TG by about 8 mg/dl and decreased HDL-C by about 1 mg/dl. Insulin and glucose had no significant effects on HDL-C, LDL-C, TG, or TC. Men who were frequent drinkers had significantly higher levels of HDL-C, and men who were more physically active had significantly lower LDL-C and TC. There were no additional effects of smoking on either HDL-C, LDL-C, TG, or TC in men.
Women
The final models for women show a significant increase in TC with age until about 58 years, but after including the other covariates, age was not a significant factor affecting HDL-C, LDL-C, or TG. For a 1 kg/m 2 increase in FMI, there was an average significant increase of 2 mg/dl in LDL-C, about 3 mg/dl in TG, 2 mg/dl in TC, and an average significant decrease of about 1 mg/dl in HDL-C. Increases in FFMI were significantly related to increases in TG, but not to HDL-C. An increase in FFMI of 1 kg/m 2 resulted in an average increase of about 6 mg/dl in TG. There were no significant effects of glucose on HDL-C, LDL-C, TG, or TC. Insulin had a significant effect only on TG. For a 1 mU/ml increase in insulin, there was an average increase of 2 mg/dl in TG. Physically active women had significantly higher HDL levels than less active women. There were no effects of smoking or drinking on either HDL-C, LDL-C, TG, or TC in women. Data from premenopausal examinations were compared to those from a combined group of peri-and postmenopausal examinations. No significant differences in the patterns of change in HDL-C, LDL-C, TG, or TC were found between surgically and naturally postmenopausal women. Therefore, data from examinations with both types of postmenopause were combined for these analyses. Change in menopausal status was related to HDL-C, LDL-C, TG, and TC levels, and estrogen use was related to HDL-C, TG, and TC levels.
Calculated mean values of HDL-C, LDL-C, TG, and TC from each model for pre-versus combined peri-and postmenopausal estrogen users and nonusers are shown in Figure 1 . Although premenopausal women had significantly lower LDL-C than women in the peri-or postmenopausal stage, estrogen use was not significantly related to LDL-C levels. Estrogen use was significantly related to HDL-C, TG, and TC levels. Premenopausal women not using estrogen Table 5 Parameter estimates (standard error) from the final selected random effects models describing age-and body composition-related changes with covariates in lipid and lipoproteins for men and women
Men Women The value is for non-or infrequent drinkers in comparison to frequent drinkers. b The value and its significance are in reference to peri-and postmenopausal women using estrogen replacement. The value is in reference to peri-and postmenopausal group.
Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age CM Schubert et al had significantly lower HDL-C, TG, and TC than peri-and postmenopausal women using estrogen. For example, a premenopausal nonuser had about 6 units less HDL-C, 39 units less TG, and 12 units lower TC than the average peri-or postmenopausal estrogen user. Peri-and postmenopausal women not using estrogen had significantly less TG than peri-and postmenopausal estrogen users (about 30 units less on average).
Discussion
BMI is often used as a surrogate for adiposity and body size because of its relationships with body fat, mortality, and morbidity. 38, 39 Between the ages of 40 and 60 years, annual increases in BMI average about 0.11 kg/m 2 in men and 0.22 kg/m 2 in women, and annual increases in weight average about 0.3 kg in men and 0.55 kg in women. 40 As people age, however, the relative amount of fat mass to lean mass increases. Since BMI does not distinguish between these components, it is important to consider the changing levels of both fat and lean tissues when examining the influence of body composition on cardiovascular and coronary artery disease risk factors. Therefore, we sought to determine if changes in fat and fat-free mass components of BMI and related lifestyle factors account for changes in lipid and lipoprotein values more so than aging per se.
In this study of middle-aged men and women, we analyzed long-term serial lipid and lipoprotein data with concurrent measures of body composition, glucose and insulin measures, physical activity, alcohol use and smoking, and menopausal status and estrogen use in women. The use of time-varying covariates allowed for the simultaneous adjustment of concurrent body composition, lipid and lipoprotein measures. In addition, the use of long-term serial data allowed for better characterization of the covariation of lipid profiles and body composition within individuals. This is particularly important when slower physiological changes in adulthood require longer study periods in order to observe significant trends.
Increases in FMI were significantly related to decreasing levels of HDL-C and increasing levels of LDL-C, TG, and TC in both men and women. Although we observed significant increases in TG and decreases in HDL-C with FFMI in men and women, we found no significant independent effects of FFMI on LDL-C or TC in either sex. These results suggest that the FMI has a greater effect on overall lipid levels in middleaged individuals than does the FFMI.
After inclusion of FMI, FFMI, and other covariates, significant independent effects of age remained only for LDL-C and TC in men, and for TC in women. This suggests that most of the age-related changes in HDL-C, LDL-C (for women), and TG can be accounted for by changes in body composition, and in women, the menopausal transition and insulin. Nevertheless, overall TC levels still vary with age, Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age CM Schubert et al perhaps due to other factors such as genetic and nutritional exposures not addressed in this study. The curvilinear fit of age to LDL-C and TC in men showed increases in these measures only until about 52 years. Other studies of serial and cross-sectional data have found similar associations of LDL-C and TC with age for men. 1, [3] [4] [5] [6] [7] 20 Our earlier examination of age-related changes in lipid and lipoprotein levels in Fels Longitudinal Study subjects, without time-varying covariates or concurrent measures of body composition as used in this paper, showed age-related declines in LDL-C and TC levels in a group aged 45-65 years. 6 Ferrara et al. 20 reported declines in LDL-C and TC 6 found no significant correlation between HDL-C and age in men or women from 45 to 65 years. This supports our current findings in which age was not a significant predictor of HDL-C in men or women. There were a number of significant covariate effects beyond those for age, FMI and FFMI. Although glucose had no effects on TG, current insulin level was associated with higher TG. The independent effect of activity on LDL-C and TC in men and on HDL-C in women suggests that physical activity and a decreased fat mass have the greatest beneficial effect on lipid and lipoprotein profiles. Combined menopausal status and estrogen use in women was associated with increases in HDL-C, TG, and TC levels. It has long been suggested in some studies that hormones contained in supplemental estrogen preparations may elevate HDL-C and TG levels and lower LDL-C levels. [41] [42] [43] [44] In the present study, peri-and postmenopausal women using estrogen replacement had higher HDL-C, TG, and TC than premenopausal women who were not using supplemental estrogen, and higher TG than postmenopausal women not using estrogen replacement. There were no effects of estrogen use on LDL-C levels in women, but the menopausal transition was positively associated with increased LDL-C. The significant effects of increases in FFMI on decreases in HDL-C and increases in TG in men and women may seem counterintuitive since physical activity is positively associated with increased lean mass, decreased fat mass, and more beneficial lipid and lipoprotein profiles. Pietrobelli et al. 45 describe potential factors and metabolic effects relating decreases in TBF and weight from aerobic activity to elevated HDL-C levels. They, 45 and others, [46] [47] [48] contend that increases in muscle mass from anaerobic exercise may cause HDL-C levels to decrease. The results from these studies and the findings in the present study suggest that independent increases in FFM without accompanying decreases in fat mass can result in decreased HDL-C concentrations. It is worthwhile to note that for most individuals within the age range of the present study, typical patterns of body composition changes are characterized by increases in fat mass (FMI) and decreases in overall muscle mass (FFMI), even though slight increases in muscle mass accompany larger increases in body fat due to greater mechanical loading of the skeleton with increased fat weight. This is the pattern that most age-related studies using BMI observe. Without accounting for both the FMI and the FFMI, however, the effect of the FFMI is masked by that of the FMI. Although age remained a significant predictor of LDL-C and TC in men and TC in women, components of body composition were found to be more influential overall on changes in lipid and lipoprotein measures than age. The FMI was significantly related to all lipid and lipoprotein measures, and the FFMI was important in describing changes in HDL-C and TG levels. Insulin was independently important for TG levels in women. In addition, lifestyle factors and the female menopausal transition influenced changes in HDL-C, LDL-C, TG, and TC levels. These findings demonstrate the influence of these risk factors on lipid and lipoprotein measures during middle age. Furthermore, they suggest that using only age or BMI may mask these important determinants of lipid and lipoproteins.
Our study is limited by the lack of dietary data documenting macronutrient intake, which is known to affect lipid levels. 49, 50 In addition, the FMI and FFMI treat all adipose tissue depots as metabolically similar, despite evidence that visceral fat depots have an independent influence on lipid levels beyond that of overall fat mass. 51 Further investigation of the relationship between FMI and FFMI with emphasis on regional fat and muscle distribution and macronutrient intake would further elucidate the associations reported here regarding the changes in lipid and lipoproteins.
Conclusion
Although BMI is an established risk factor influencing lipid and lipoprotein levels, components of BMI affect these lipid measures to different degrees. As the adiposity component of BMI, FMI is the major contributor to changes in HDL-C, LDL-C, TG, and TC for men and women during middle age. Additionally, FFMI plays a significant role in the patterns of change in HDL-C and TG. In women, the inclusion of FMI, FFMI, insulin, and menopausal status accounts for the observed age-related changes in all lipid and lipoprotein measures except TC. Age remains an important predictor variable of LDL-C and TC in men, and TC in women. Changes in lipid and lipoprotein measures are also influenced by modifiable factors related to both of the body composition components within the individual. Independent increases in muscle mass without accompanying decreases in body fat result in lower HDL-C and TC levels on average in both men and women. Lowering BMI by Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age CM Schubert et al decreasing TBF through aerobic activity may be more beneficial in decreasing cardiovascular disease risk via decreased lipid and lipoprotein levels than other interventions. Further investigation into the mechanisms by which HDL-C, LDL-C, TG, and TC levels are affected by relative changes in TBF and FFM may improve cardiovascular disease risk assessment over that of current methods using only age and BMI.
